This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yee, C. Articles by Howley, P. M. Search for Related Content PubMed PubMed Citation Articles by Yee, C. Articles by Howley, P. M.

American Journal of Pathology, Vol 119, 361-366, Copyright © 1985 by American Society for Investigative Pathology

REGULAR ARTICLES

Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines

C Yee, I Krishnan-Hewlett, CC Baker, R Schlegel and PM Howley

A series of human carcinoma cell lines was examined for human papillomavirus (HPV) DNA sequences with the use of HPV-6, HPV-11, HPV- 16, and HPV-18 DNA probes. Six of eight cell lines derived from human cervical carcinomas were shown to contain integrated HPV DNA sequences. In five of these six lines, HPV-specific polyadenylated RNA species could also be identified. The expression of HPV sequences was detected in three lines with a HPV-18 DNA probe and in two lines with a HPV-16 DNA probe. Of the two lines which contained HPV-16 specific RNA, one contained HPV DNA sequences which hybridized only to an HPV-16 probe, and the other contained HPV DNA sequences which hybridized to both HPV- 16 and HPV-18 DNA probes. Six cell lines established from human squamous-cell carcinomas of the bladder, pharynx, lung, esophagus, and vulva were negative for HPV-6, HPV-11, HPV-16, and HPV-18 DNA sequences under stringent hybridization conditions.

This article has been cited by other articles:

				M. L. Nguyen, R. M. Kraft, M. Aubert, E. Goodwin, D. DiMaio, and J. A. Blaho p53 and hTERT Determine Sensitivity to Viral Apoptosis J. Virol., December 1, 2007; 81(23): 12985 - 12995. [Abstract] [Full Text] [PDF]

				M. Sandoval, M. Morales, R. Tapia, L. del Carmen Alarcon, M. Sordo, P. Ostrosky-Wegman, A. Ortega, and E. Lopez-Bayghen p53 Response to Arsenic Exposure in Epithelial Cells: Protein Kinase B/Akt Involvement Toxicol. Sci., September 1, 2007; 99(1): 126 - 140. [Abstract] [Full Text] [PDF]

				W.-O. Lui, N. Pourmand, B. K. Patterson, and A. Fire Patterns of Known and Novel Small RNAs in Human Cervical Cancer Cancer Res., July 1, 2007; 67(13): 6031 - 6043. [Abstract] [Full Text] [PDF]

				S. R. Bartz, Z. Zhang, J. Burchard, M. Imakura, M. Martin, A. Palmieri, R. Needham, J. Guo, M. Gordon, N. Chung, et al. Small Interfering RNA Screens Reveal Enhanced Cisplatin Cytotoxicity in Tumor Cells Having both BRCA Network and TP53 Disruptions Mol. Cell. Biol., December 15, 2006; 26(24): 9377 - 9386. [Abstract] [Full Text] [PDF]

				M.T. Herdman, M. R. Pett, I. Roberts, W. O.F. Alazawi, A. E. Teschendorff, X.-Y. Zhang, M. A. Stanley, and N. Coleman Interferon-{beta} treatment of cervical keratinocytes naturally infected with human papillomavirus 16 episomes promotes rapid reduction in episome numbers and emergence of latent integrants Carcinogenesis, November 1, 2006; 27(11): 2341 - 2353. [Abstract] [Full Text] [PDF]

				M. G. McPhillips, J. G. Oliveira, J. E. Spindler, R. Mitra, and A. A. McBride Brd4 Is Required for E2-Mediated Transcriptional Activation but Not Genome Partitioning of All Papillomaviruses J. Virol., October 1, 2006; 80(19): 9530 - 9543. [Abstract] [Full Text] [PDF]

				J. L. Parish, A. Kowalczyk, H.-T. Chen, G. E. Roeder, R. Sessions, M. Buckle, and K. Gaston E2 Proteins from High- and Low-Risk Human Papillomavirus Types Differ in Their Ability To Bind p53 and Induce Apoptotic Cell Death J. Virol., May 1, 2006; 80(9): 4580 - 4590. [Abstract] [Full Text] [PDF]

				M. Jiang, A. A. Arzumanov, M. J. Gait, and J. Milner A bi-functional siRNA construct induces RNA interference and also primes PCR amplification for its own quantification Nucleic Acids Res., October 7, 2005; 33(18): e151 - e151. [Abstract] [Full Text] [PDF]

				K.-W. Huh, J. DeMasi, H. Ogawa, Y. Nakatani, P. M. Howley, and K. Munger Association of the human papillomavirus type 16 E7 oncoprotein with the 600-kDa retinoblastoma protein-associated factor, p600 PNAS, August 9, 2005; 102(32): 11492 - 11497. [Abstract] [Full Text] [PDF]

				H. M. Zhang, J. Yuan, P. Cheung, D. Chau, B. W. Wong, B. M. McManus, and D. Yang Gamma Interferon-Inducible Protein 10 Induces HeLa Cell Apoptosis through a p53-Dependent Pathway Initiated by Suppression of Human Papillomavirus Type 18 E6 and E7 Expression Mol. Cell. Biol., July 15, 2005; 25(14): 6247 - 6258. [Abstract] [Full Text] [PDF]

				N. A. Patterson, J. L. Smith, and M. A. Ozbun Human Papillomavirus Type 31b Infection of Human Keratinocytes Does Not Require Heparan Sulfate J. Virol., June 1, 2005; 79(11): 6838 - 6847. [Abstract] [Full Text] [PDF]

				R. E. Oberley, K. L. Goss, K. A. Ault, E. C. Crouch, and J. M. Snyder Surfactant protein D is present in the human female reproductive tract and inhibits Chlamydia trachomatis infection Mol. Hum. Reprod., December 1, 2004; 10(12): 861 - 870. [Abstract] [Full Text] [PDF]

				B. A. Van Tine, J. C. Kappes, N. S. Banerjee, J. Knops, L. Lai, R. D. M. Steenbergen, C. L. J. M. Meijer, P. J. F. Snijders, P. Chatis, T. R. Broker, et al. Clonal Selection for Transcriptionally Active Viral Oncogenes during Progression to Cancer J. Virol., October 15, 2004; 78(20): 11172 - 11186. [Abstract] [Full Text] [PDF]

				T. A. Miura, H. Li, K. Morris, S. Ryan, K. Hembre, J. L. Cook, and J. M. Routes Expression of an E1A/E7 Chimeric Protein Sensitizes Tumor Cells to Killing by Activated Macrophages but Not NK Cells J. Virol., May 1, 2004; 78(9): 4646 - 4654. [Abstract] [Full Text] [PDF]

				Y. Kluger, D. P. Tuck, J. T. Chang, Y. Nakayama, R. Poddar, N. Kohya, Z. Lian, A. B. Nasr, H. R. Halaban, D. S. Krause, et al. Lineage specificity of gene expression patterns PNAS, April 27, 2004; 101(17): 6508 - 6513. [Abstract] [Full Text] [PDF]

				K. Middleton, W. Peh, S. Southern, H. Griffin, K. Sotlar, T. Nakahara, A. El-Sherif, L. Morris, R. Seth, M. Hibma, et al. Organization of Human Papillomavirus Productive Cycle during Neoplastic Progression Provides a Basis for Selection of Diagnostic Markers J. Virol., October 1, 2003; 77(19): 10186 - 10201. [Abstract] [Full Text] [PDF]

				I. Kuzmin, L. Liu, R. Dammann, L. Geil, E. J. Stanbridge, S. P. Wilczynski, M. I. Lerman, and G. P. Pfeifer Inactivation of RAS Association Domain Family 1A Gene in Cervical Carcinomas and the Role of Human Papillomavirus Infection Cancer Res., April 15, 2003; 63(8): 1888 - 1893. [Abstract] [Full Text] [PDF]

				V. Bechtold, P. Beard, and K. Raj Human Papillomavirus Type 16 E2 Protein Has No Effect on Transcription from Episomal Viral DNA J. Virol., February 1, 2003; 77(3): 2021 - 2028. [Abstract] [Full Text] [PDF]

				M. A. Ozbun Human Papillomavirus Type 31b Infection of Human Keratinocytes and the Onset of Early Transcription J. Virol., October 11, 2002; 76(22): 11291 - 11300. [Abstract] [Full Text] [PDF]

				A. Roda, M. Mirasoli, S. Venturoli, M. Cricca, F. Bonvicini, M. Baraldini, P. Pasini, M. Zerbini, and M. Musiani Microtiter Format for Simultaneous Multianalyte Detection and Development of a PCR-Chemiluminescent Enzyme Immunoassay for Typing Human Papillomavirus DNAs Clin. Chem., October 1, 2002; 48(10): 1654 - 1660. [Abstract] [Full Text] [PDF]

				J. L. Bronder and R. G. Moran Antifolates Targeting Purine Synthesis Allow Entry of Tumor Cells into S Phase Regardless of p53 Function Cancer Res., September 15, 2002; 62(18): 5236 - 5241. [Abstract] [Full Text] [PDF]

				P. Peitsaro, B. Johansson, and S. Syrjanen Integrated Human Papillomavirus Type 16 Is Frequently Found in Cervical Cancer Precursors as Demonstrated by a Novel Quantitative Real-Time PCR Technique J. Clin. Microbiol., March 1, 2002; 40(3): 886 - 891. [Abstract] [Full Text] [PDF]

				J. R. Caceres-Cortes, J. A. Alvarado-Moreno, K. Waga, R. Rangel-Corona, A. Monroy-Garcia, L. Rocha-Zavaleta, J. Urdiales-Ramos, B. Weiss-Steider, A. Haman, P. Hugo, et al. Implication of Tyrosine Kinase Receptor and Steel Factor in Cell Density-dependent Growth in Cervical Cancers and Leukemias Cancer Res., August 1, 2001; 61(16): 6281 - 6289. [Abstract] [Full Text] [PDF]

				A. N. Player, L.-P. Shen, D. Kenny, V. P. Antao, and J. A. Kolberg Single-copy Gene Detection Using Branched DNA (bDNA) In Situ Hybridization J. Histochem. Cytochem., May 1, 2001; 49(5): 603 - 612. [Abstract] [Full Text]

				J. Schwab and H. Illges Regulation of CD21 expression by DNA methylation and histone deacetylation Int. Immunol., May 1, 2001; 13(5): 705 - 710. [Abstract] [Full Text] [PDF]

				H. z. Hausen Cervical Carcinoma and Human Papillomavirus: On the Road to Preventing a Major Human Cancer J Natl Cancer Inst, February 21, 2001; 93(4): 252 - 253. [Full Text] [PDF]

				M. Stevenson, L. C. Hudson, J. E. Burns, R. L. Stewart, M. Wells, and N. J. Maitland Inverse relationship between the expression of the human papillomavirus type 16 transcription factor E2 and virus DNA copy number during the progression of cervical intraepithelial neoplasia J. Gen. Virol., July 1, 2000; 81(7): 1825 - 1832. [Abstract] [Full Text]

				M. L. Gillison, W. M. Koch, R. B. Capone, M. Spafford, W. H. Westra, L. Wu, M. L. Zahurak, R. W. Daniel, M. Viglione, D. E. Symer, et al. Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck Cancers J Natl Cancer Inst, May 3, 2000; 92(9): 709 - 720. [Abstract] [Full Text] [PDF]

				F. A. Suprynowicz, J. Sparkowski, A. Baege, and R. Schlegel E5 Oncoprotein Mutants Activate Phosphoinositide 3-Kinase Independently of Platelet-derived Growth Factor Receptor Activation J. Biol. Chem., February 18, 2000; 275(7): 5111 - 5119. [Abstract] [Full Text] [PDF]

				M. Vaxillaire, A. Abderrahmani, P. Boutin, B. Bailleul, P. Froguel, M. Yaniv, and M. Pontoglio Anatomy of a Homeoprotein Revealed by the Analysis of Human MODY3 Mutations J. Biol. Chem., December 10, 1999; 274(50): 35639 - 35646. [Abstract] [Full Text] [PDF]

				M. Yoshinouchi, A. Hongo, K. Nakamura, J. Kodama, S. Itoh, H. Sakai, and T. Kudo Analysis by Multiplex PCR of the Physical Status of Human Papillomavirus Type 16 DNA in Cervical Cancers J. Clin. Microbiol., November 1, 1999; 37(11): 3514 - 3517. [Abstract] [Full Text]

				D. Ndisang, V. Budhram-Mahadeo, and D. S. Latchman The Brn-3a Transcription Factor Plays a Critical Role in Regulating Human Papilloma Virus Gene Expression and Determining the Growth Characteristics of Cervical Cancer Cells J. Biol. Chem., October 1, 1999; 274(40): 28521 - 28527. [Abstract] [Full Text] [PDF]

				H. J. Bontkes, T. D. de Gruijl, A. Bijl, R. H. M. Verheijen, C. J. L. M. Meijer, R. J. Scheper, P. L. Stern, J. E. Burns, N. J. Maitland, and J. M. M. Walboomers Human papillomavirus type 16 E2-specific T-helper lymphocyte responses in patients with cervical intraepithelial neoplasia J. Gen. Virol., September 1, 1999; 80(9): 2453 - 2459. [Abstract] [Full Text]

				S. Song, H. C. Pitot, and P. F. Lambert The Human Papillomavirus Type 16 E6 Gene Alone Is Sufficient To Induce Carcinomas in Transgenic Animals J. Virol., July 1, 1999; 73(7): 5887 - 5893. [Abstract] [Full Text]

				K. Smith-McCune, D. Kalman, C. Robbins, S. Shivakumar, L. Yuschenkoff, and J. M. Bishop Intranuclear localization of human papillomavirus 16 E7 during transformation and preferential binding of E7 to the Rb family member p130 PNAS, June 8, 1999; 96(12): 6999 - 7004. [Abstract] [Full Text] [PDF]

				L. K. Naeger, E. C. Goodwin, E.-S. Hwang, R. A. DeFilippis, H. Zhang, and D. DiMaio Bovine Papillomavirus E2 Protein Activates a Complex Growth-inhibitory Program in p53-negative HT-3 Cervical Carcinoma Cells that Includes Repression of Cyclin A and cdc25A Phosphatase Genes and Accumulation of Hypophosphorylated Retinoblastoma Protein Cell Growth Differ., June 1, 1999; 10(6): 413 - 422. [Abstract] [Full Text]

				R. H. See and Y. Shi Adenovirus E1B 19,000-Molecular-Weight Protein Activates c-Jun N-Terminal Kinase and c-Jun-Mediated Transcription Mol. Cell. Biol., July 1, 1998; 18(7): 4012 - 4022. [Abstract] [Full Text]

				E. C. Goodwin, L. K. Naeger, D. E. Breiding, E. J. Androphy, and D. DiMaio Transactivation-Competent Bovine Papillomavirus E2 Protein Is Specifically Required for Efficient Repression of Human Papillomavirus Oncogene Expression and for Acute Growth Inhibition of Cervical Carcinoma Cell Lines J. Virol., May 1, 1998; 72(5): 3925 - 3934. [Abstract] [Full Text] [PDF]

				L. Suzuk, A. E. Noffsinger, M. Ali, and C. M. Fenoglio-Preiser A High Frequency of Human Papilloma Virus (HPV) DNA Type 16 in Biopsies of Cervical Squamous Cell Neoplasia of Uygur Women International Journal of Surgical Pathology, April 1, 1997; 4(4): 219 - 225. [Abstract] [PDF]

				G J Nuovo, G A Gorgone, P MacConnell, M Margiotta, and P D Gorevic In situ localization of PCR-amplified human and viral cDNAs. Genome Res., November 1, 1992; 2(2): 117 - 123. [Abstract] [PDF]

				H zur Hausen Viruses in human cancers Science, November 22, 1991; 254(5035): 1167 - 1173. [Abstract] [PDF]

				H Hirochika, R Hirochika, T R Broker, and L T Chow Functional mapping of the human papillomavirus type 11 transcriptional enhancer and its interaction with the trans-acting E2 proteins. Genes & Dev., January 1, 1988; 2(1): 54 - 67. [Abstract] [PDF]